FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices

The FDA's proactive call for feedback marks a critical pivot toward establishing safety guardrails for generative AI in healthcare settings. By formalizing these regulatory pathways, the agency aims to balance rapid medical innovation with the urgent need to mitigate risks like diagnostic bias and clinical hallucinations.